Skip to content
buyWeak cluster of 410b5-1 plan

James Jones bought $1,166 of CPIX

director at CUMBERLAND PHARMACEUTICALS INC. 340 shares at an average of $3.43, traded Jul 1, 2025, filed Aug 11, 2025.

Conviction score
23
Value
$1,166
340 shares
Holdings after
43,676
+1% from before
From 52-week low
+229%
low $0.82, close $2.71
From 52-week high
-48%
high $5.25, as of Jul 1, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $1k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.8%)
    -5
  • Price context
    48% below the 52-week high
    +8
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    3 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (1 with prices)
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -15

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CPIXOct 9, 2026 · close 7.03
Since filing Aug 11, 2025: +219.2%SPY +24.1% · excess +195.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-039404, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 1, 2025POpen-market purchase
Common Stock10b5-1
+16$3.56$5743,352Aug 11, 2025
Jul 2, 2025POpen-market purchase
Common Stock10b5-1
+16$3.52$5643,368Aug 11, 2025
Jul 3, 2025POpen-market purchase
Common Stock10b5-1
+16$3.31$5343,384Aug 11, 2025
Jul 7, 2025POpen-market purchase
Common Stock10b5-1
+16$3.23$5243,400Aug 11, 2025
Jul 8, 2025POpen-market purchase
Common Stock10b5-1
+16$3.06$4943,416Aug 11, 2025
Jul 9, 2025POpen-market purchase
Common Stock10b5-1
+16$3.05$4943,432Aug 11, 2025
Jul 10, 2025POpen-market purchase
Common Stock10b5-1
+16$3.20$5143,448Aug 11, 2025
Jul 11, 2025POpen-market purchase
Common Stock10b5-1
+16$3.21$5143,464Aug 11, 2025
Jul 14, 2025POpen-market purchase
Common Stock10b5-1
+16$3.46$5543,480Aug 11, 2025
Jul 15, 2025POpen-market purchase
Common Stock10b5-1
+16$3.45$5543,496Aug 11, 2025
Jul 16, 2025POpen-market purchase
Common Stock10b5-1
+16$3.79$6143,512Aug 11, 2025
Jul 17, 2025POpen-market purchase
Common Stock10b5-1
+16$3.82$6143,528Aug 11, 2025
Jul 18, 2025POpen-market purchase
Common Stock10b5-1
+16$3.59$5743,544Aug 11, 2025
Jul 21, 2025POpen-market purchase
Common Stock10b5-1
+16$3.45$5543,560Aug 11, 2025
Jul 22, 2025POpen-market purchase
Common Stock10b5-1
+16$3.47$5643,576Aug 11, 2025
Jul 23, 2025POpen-market purchase
Common Stock10b5-1
+16$3.54$5743,592Aug 11, 2025
Jul 24, 2025POpen-market purchase
Common Stock10b5-1
+16$3.55$5743,608Aug 11, 2025
Jul 25, 2025POpen-market purchase
Common Stock10b5-1
+16$3.37$5443,624Aug 11, 2025
Jul 28, 2025POpen-market purchase
Common Stock10b5-1
+13$3.47$4543,637Aug 11, 2025
Jul 29, 2025POpen-market purchase
Common Stock10b5-1
+13$3.33$4343,650Aug 11, 2025
Jul 30, 2025POpen-market purchase
Common Stock10b5-1
+13$3.55$4643,663Aug 11, 2025
Jul 31, 2025POpen-market purchase
Common Stock10b5-1
+13$3.50$4643,676Aug 11, 2025

Related signals

Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,516
1,372 shares
+0%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$862
262 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$862
262 shares
+1%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$398
121 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$5,872
1,712 shares
+1%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$1,166
340 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$578
168 shares
+1%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,513
935 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$807
168 shares
+0%
29Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$807
168 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

James Jones bought $1,166 of CPIX | InsiderTell